CSO Ghana Report 2012


Published on

Presented by George Hedidor at CSO Project Meeting, Cuenca, Ecuador, 15-17 November 2012

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

CSO Ghana Report 2012

  1. 1. The AMR Project in Ghana George Hedidor – Interim CoordinatorOn behalf of the Project Lead and the AMR working group, Ghana
  2. 2. Background Its common knowledge that use of antibiotics is not optimal in Ghana and Africa as a whole (Contributing to the increased prevalence and spread of Antibiotic resistance[ABR]) Problems exist with regards to the quality of antibiotics available and used in the country (Impacting on access to quality, safe and effective antibiotics (RUM)) There are issues related to weak health system, enforcement of regulations bordering on market authorisation and the supply of antibiotics leading to unrestricted access, over use and
  3. 3.  The use of antibiotics for disease prevention and growth promotion in animal husbandry, and the reported existence of antibiotic residues in food chain Evidence exist currently to show that many infecting pathogens are failing to respond to the common and potent antimicrobials available (Increased morbidity and mortality from microbial infections) Bacterial isolates that were sensitive to common and affordable antibiotics in the health system are now multi-drug resistant
  4. 4.  The threat of antibiotic resistance is real and has serious health and economic implications Marked decrease in the pipeline for the development of new antimicrobials with novel mechanisms of action to deal with drug resistant & multidrug resistant strain of pathogens The need to address the problem led to the formation of the National Antimicrobial Resistance Working Group (AMR WG), supported by International collaborators; ReACT (SIDA)
  5. 5. AMR- WGCHARACTERISTICS Multidisciplinary in nature with representation from all sectors in the health & other determinants in the health system, other stakeholders like CSOs. Institutions/Organisations represented include: MoH/GHS (Dep Minister & CD, Directors for Institutional Care & Pharmaceutical Services) - direction and ownership Consultant Clinicians from Teaching hospitals & Ghana college of Physicians and Surgeons - technical and expertise inputs Academic Institutions/Universities involved with research in health systems/health services, Clinical Microbiology and Pharmacy – research, data and evidence generation
  6. 6. continue from previous slide.. Vetinary Medicine Practitioners & Researchers – animal use Regulatory authorities in the Pharmaceutical Industry such as Food & Drugs Board and Pharmacy Council – law enforcement Pharmaceutical Manufacturers Association – industry  Civil Society Organisation - consumer and advocacy  Lapag, Coalition of NGOs in Health, CSHC Health professional bodies: eg. Nurses & Midwives , Doctors and pharmacists WHO – sub-regional strategic direction Water and Sanitation INDEPTH – strategic in surveillance on antibiotics Media – channels for communication Supported technically and financially by our International
  7. 7. Goal of the AMR Working Group To develop and implement a comprehensive national AMR policy Propose action points to guide the development of a national policy that addresses antibiotic use and the prevention and management of AMR (But the initial focus is on issues related to antibiotic use & resistance to generate data) Strengthen partnership with international collaborators; ReACT, ReAct partners, GARP and all major stakeholders to develop a platform to discuss and address issues related to antibiotic use and resistance as well as its health and economic implications (Phd work in the offering)
  8. 8. Specific Objective(s) To analyse the local situation to generate data As part of the process the under listed activities are to be undertaken (evidence to feed policy): To review the KABP of health professionals and on CSOs on antibiotics and antibiotic resistance Surveillance on antibiotic use and resistance in health facilities and in the communities
  9. 9. Develop the capacity of health professionals and laboratories to deal with issues related to AB and resistance in the health systemLink medicine selection to evidence from antibiotic surveillance and antibiotic resistant patternsReview and enforce the regulations on antibiotic medicines management in GhanaTo promote research that encourages the generation of data for BCC and the promotion of rational use of antibioticsEngage CSO for social mobilization, health education and communication
  10. 10. The Ghana Project Ghana is running two projects under different agreement but same focus: ◦ NPAR project (addresses some aspects on ABR which is not directly captured in the CSO project) ◦ CSO project ◦ Funding from SIDA (ReACT- Sweden) To ensure focus: ◦ A comprehensive concept note detailing the goals and objectives have been developed; (prevent duplication, ownership, captures cso work)
  11. 11. So far... Several stakeholders meeting have been held where important issues regarding activities and data generation discussed and actions taken (Discussions have been enriched with the participation of experts from ReACT ) ReACT and partners have actively supported the Ghana working group
  12. 12.  The NPAR contract documents has been signed between the CD of MoH and ReAct, Sweden Following that a request was made for the release of funds for the NPAR project; honoured by ReACT in September 2012 On the CSO’s project, the contract documents and ToR have also been signed by ReACT & MoH in September. Request was made for the release of funds (lodged in the accounts on October 18 2012)
  13. 13.  The research subgroup have worked on a proposal for KABP study and Antibiotic use in the community. [Narrowing the focus to meet project and budget needs] This protocol is also being adapted for use on health professionals (health care providers; public sector; private...?) ◦ The KABP on both professionals and CSOs will hopefully be done by the end of november 2012
  14. 14. Letters of Aggreements and Timelines A meeting was held with the representatives of the CSOs to strategise on project implementation. ◦ Review the LoAs to reflect activities and budget for 2012 and push the rest to 2013 ◦ CSOs requested to meet from 24th to define the time lines for 2013 ◦ Agreed to carry out the KABP through to dissemination of results for 2012
  15. 15.  Ghana AMR website has been developed and launched on the back of GNDP website (still under development) (http://ghndp.org/antimicrobialresistan ce/) Protocol for needs assessment and monitoring of antibiotic resistance in some selected hospitals (NPAR)
  16. 16. Sensitizations forums AGM for Pharmacist: Conference of the Pharmaceutical Society of Ghana this year to discuss issues related to antibiotic use and resistance and the role of Pharmacists in addressing the issues Coalition of NGOs in health (22nd November) LAPAG – sensitizes its members and community on appropriate use of medicines, in sports, in pregnancy, lactation, in WOMEN from childhood, adolescence thru reproduction, menopause etc)
  17. 17. Current Challenges: The working group have less than a month to implement the activities slated for this year Usually the last quarter of the year is a period for stocktaking, report writing and forecasting for the impending year in most governmental agencies The year 2012 is also an election year and this presents people organisation challenges !!!
  18. 18. By December 2012 KABP survey: ◦ for CSOs ◦ Health Providers in the public hospitals (community and private..?) ◦ Dissemination of KABP results Stakeholder Mapping (NPAR) Needs assessment on antibiotic use surveillance Sensitizations
  19. 19.  Cartoon by jparables (CSHC)
  20. 20.  THANK YOU GRACIAS